These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 9440125

  • 1. Transneuronal degeneration in the spread of Alzheimer's disease pathology: immunohistochemical evidence for the transmission of tau hyperphosphorylation.
    Su JH, Deng G, Cotman CW.
    Neurobiol Dis; 1997; 4(5):365-75. PubMed ID: 9440125
    [Abstract] [Full Text] [Related]

  • 2. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA, Nafe R, Schlote W.
    Brain Res; 2008 Jun 05; 1213():152-65. PubMed ID: 18455153
    [Abstract] [Full Text] [Related]

  • 3. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I, Barrachina M, Puig B.
    Acta Neuropathol; 2002 Dec 05; 104(6):583-91. PubMed ID: 12410379
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A, Shepherd CE, Sokolova A, Carroll VL, King AE, Halliday GM, Dickson TC, Vickers JC.
    Acta Neuropathol; 2009 Jan 05; 117(1):19-29. PubMed ID: 19015863
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
    Walton JR.
    J Inorg Biochem; 2007 Sep 05; 101(9):1275-84. PubMed ID: 17662457
    [Abstract] [Full Text] [Related]

  • 13. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
    Wang YJ, Chen GH, Hu XY, Lu YP, Zhou JN, Liu RY.
    Brain Res; 2005 Jan 07; 1031(1):101-8. PubMed ID: 15621017
    [Abstract] [Full Text] [Related]

  • 14. Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes.
    van de Nes JA, Sandmann-Keil D, Braak H.
    Acta Neuropathol; 2002 Oct 07; 104(4):351-6. PubMed ID: 12200620
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
    Gómez-Ramos P, Morán MA.
    Microsc Res Tech; 1998 Oct 01; 43(1):49-58. PubMed ID: 9829459
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.